Armata Pharmaceuticals ARMP
NYSE ARMP
$3.83 +0.08 (+2.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Armata Pharmaceuticals (ARMP) Restructuring Costs (2009 - 2015)

Updated

Armata Pharmaceuticals' Restructuring Costs was $289,000 in FY2015, down 84.5% from $1.86 million in FY2014.

Analysis

Armata Pharmaceuticals (ARMP) Restructuring Costs (2009 - 2015) Analysis & Trends

  • Per Business Quant data, Restructuring Costs in earlier years was $1.86 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Armata Pharmaceuticals 137.07 Mn 84.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 289,000.00
Dec 31, 2014 24,000.00
Jun 30, 2009 -276,000.00
Mar 31, 2009 334,000.00
API Access

Armata Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ARMP&period=max&api_key=YOUR_API_KEY